U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

BRCA1 BRCA1 DNA repair associated [ Homo sapiens (human) ]

Gene ID: 672, updated on 27-Nov-2024

Summary

Go to the top of the page Help
Official Symbol
BRCA1provided by HGNC
Official Full Name
BRCA1 DNA repair associatedprovided by HGNC
Primary source
HGNC:HGNC:1100
See related
Ensembl:ENSG00000012048 MIM:113705; AllianceGenome:HGNC:1100
Gene type
protein coding
RefSeq status
REVIEWED
Organism
Homo sapiens
Lineage
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo
Also known as
IRIS; PSCP; BRCAI; BRCC1; FANCS; PNCA4; RNF53; BROVCA1; PPP1R53
Summary
This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
Expression
Broad expression in testis (RPKM 5.2), lymph node (RPKM 3.3) and 23 other tissues See more
Orthologs
mouse all
NEW
Try the new Gene table
Try the new Transcript table

Genomic context

Go to the top of the page Help
See BRCA1 in Genome Data Viewer
Location:
17q21.31
Exon count:
31
Annotation release Status Assembly Chr Location
RS_2024_08 current GRCh38.p14 (GCF_000001405.40) 17 NC_000017.11 (43044295..43170327, complement)
RS_2024_08 current T2T-CHM13v2.0 (GCF_009914755.1) 17 NC_060941.1 (43902857..44029084, complement)
RS_2024_09 previous assembly GRCh37.p13 (GCF_000001405.25) 17 NC_000017.10 (41196312..41322344, complement)

Chromosome 17 - NC_000017.11Genomic Context describing neighboring genes Neighboring gene ATAC-STARR-seq lymphoblastoid silent region 8550 Neighboring gene Sharpr-MPRA regulatory region 8675 Neighboring gene vesicle amine transport 1 Neighboring gene H3K27ac-H3K4me1 hESC enhancer GRCh37_chr17:41195058-41195600 Neighboring gene Rho family GTPase 2 Neighboring gene OCT4-NANOG hESC enhancer GRCh37_chr17:41214996-41215531 Neighboring gene ReSE screen-validated silencer GRCh37_chr17:41224055-41224260 Neighboring gene BRD4-independent group 4 enhancer GRCh37_chr17:41243136-41244335 Neighboring gene ribosomal protein L21 pseudogene 4 Neighboring gene BRCA1 intronic recombination region Neighboring gene BRCA1 intron 2 regulatory region Neighboring gene BRCA1 promoter region Neighboring gene OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr17:41298599-41299208 Neighboring gene neighbor of BRCA1 lncRNA 2 Neighboring gene uncharacterized LOC101929767 Neighboring gene high mobility group nucleosome binding domain 1 pseudogene 29 Neighboring gene BRCA1P1 intergenic recombination region Neighboring gene NANOG-H3K27ac-H3K4me1 hESC enhancer GRCh37_chr17:41311429-41311959 Neighboring gene uncharacterized LOC124900391 Neighboring gene ATAC-STARR-seq lymphoblastoid active region 12236 Neighboring gene ATAC-STARR-seq lymphoblastoid active region 12237 Neighboring gene ATAC-STARR-seq lymphoblastoid active region 12238 Neighboring gene ATAC-STARR-seq lymphoblastoid active region 12239 Neighboring gene BRCA1 pseudogene 1 Neighboring gene NBR1 autophagy cargo receptor Neighboring gene Sharpr-MPRA regulatory region 10579 Neighboring gene transmembrane protein 106A

Genomic regions, transcripts, and products

Go to the top of the page Help

Go to nucleotide: Graphics FASTA GenBank

Expression

Go to the top of the page Help
  • Project title: HPA RNA-seq normal tissues
  • Description: RNA-seq was performed of tissue samples from 95 human individuals representing 27 different tissues in order to determine tissue-specificity of all protein-coding genes
  • BioProject: PRJEB4337
  • Publication: PMID 24309898
  • Analysis date: Wed Apr 4 07:08:55 2018

Bibliography

Go to the top of the pageHelp

Related articles in PubMed

  1. BRCA1 expression in invasive breast carcinomas and clinicopathological correlations. Comănescu M, et al. Rom J Morphol Embryol, 2009. PMID 19690768
  2. Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features. Tung N, et al. Breast Cancer Res, 2010. PMID 20149218, Free PMC Article
  3. Identification of breast tumor mutations in BRCA1 that abolish its function in homologous DNA recombination. Ransburgh DJ, et al. Cancer Res, 2010 Feb 1. PMID 20103620, Free PMC Article
  4. [Detection of 5382insC mutation in human BRCA1 gene using fluorescent labeled oligonucleotides]. Mitrofanov DV, et al. Mol Biol (Mosk), 2009 Nov-Dec. PMID 20088375
  5. Identification of the first case of germline duplication of BRCA1 exon 13 in an Italian family. Cerutti R, et al. Fam Cancer, 2010 Sep. PMID 20041308

See all (1000) citations in PubMed

GeneRIFs: Gene References Into Functions

What's a GeneRIF?
  1. Mechanism of BRCA1-BARD1 function in DNA end resection and DNA protection.
    Title: Mechanism of BRCA1-BARD1 function in DNA end resection and DNA protection.
  2. Exploring Molecular Drivers of PARPi Resistance in BRCA1-Deficient Ovarian Cancer: The Role of LY6E and Immunomodulation.
    Title: Exploring Molecular Drivers of PARPi Resistance in BRCA1-Deficient Ovarian Cancer: The Role of LY6E and Immunomodulation.
  3. Promotion of DNA end resection by BRCA1-BARD1 in homologous recombination.
    Title: Promotion of DNA end resection by BRCA1-BARD1 in homologous recombination.
  4. Featuring BRCA1 and BRCA2 germline mutational landscape from Asturias (North Spain).
    Title: Featuring BRCA1 and BRCA2 germline mutational landscape from Asturias (North Spain).
  5. Mutation spectra of the BRCA1/2 genes in human breast and ovarian cancer and germline.
    Title: Mutation spectra of the BRCA1/2 genes in human breast and ovarian cancer and germline.
  6. Incidence of endometrial cancer in BRCA mutation carriers.
    Title: Incidence of endometrial cancer in BRCA mutation carriers.
  7. BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.
    Title: BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance.
  8. Assessing the Impact of Novel BRCA1 Exon 11 Variants on Pre-mRNA Splicing.
    Title: Assessing the Impact of Novel BRCA1 Exon 11 Variants on Pre-mRNA Splicing.
  9. Hypermethylation of the BRCA2 gene promoter and its co-hypermethylation with the BRCA1 gene promoter in patients with breast cancer.
    Title: Hypermethylation of the BRCA2 gene promoter and its co-hypermethylation with the BRCA1 gene promoter in patients with breast cancer.
  10. DOT1L-mediated RAP80 methylation promotes BRCA1 recruitment to elicit DNA repair.
    Title: DOT1L-mediated RAP80 methylation promotes BRCA1 recruitment to elicit DNA repair.
Submit: New GeneRIF Correction See all GeneRIFs (2609)

Phenotypes

Go to the top of the page Help

Find tests for this gene in the NIH Genetic Testing Registry (GTR)

Review eQTL and phenotype association data in this region using PheGenI

Professional guidelines

Description
Professional guideline
ACMG 2013

The ACMG recommends that laboratories performing clinical sequencing seek and report mutations in BRCA1 that are pathogenic or expected to be pathogenic.

GuidelinePubMed

Copy number response

Description
Copy number response
Triplosensitivity

No evidence available (Last evaluated 2021-09-23)

ClinGen Genome Curation Page
Haploinsufficency

Sufficient evidence for dosage pathogenicity (Last evaluated 2021-09-23)

ClinGen Genome Curation PagePubMed

Variation

Go to the top of the page Help

See variants in ClinVar

See studies and variants in dbVar

See Variation Viewer (GRCh37.p13)

See Variation Viewer (GRCh38)

HIV-1 interactions

Go to the top of the page Help

Replication interactions

Interaction Pubs
Knockdown of breast cancer 1, early onset (BRCA1) by siRNA inhibits HIV-1 replication in HeLa P4/R5 cells PubMed

Protein interactions

Protein Gene Interaction Pubs
Tat tat HIV-1 Tat associates with BRCA1 in cells and the amino-acid 504-802 region of BRCA1 physically interacts with HIV-1 Tat PubMed
tat BRCA1 enhances HIV-1 Tat-dependent transcription in cells, and BRCA1 phosphorylation at positions S1387, S1423, S1457, and S1524 is important for the enhancement of Tat-dependent transcription PubMed
Vpr vpr HIV-1 Vpr stimulates the focus formation of Rad51 and BRCA1, which are involved in repair of DNA double-strand breaks (DSBs) by homologous recombination (HR) PubMed
vpr HIV-1 Vpr induces phosphorylation of BRCA1 at serine 1423 in an ATR-dependent manner PubMed
vpr HIV-1 Vpr expression in HeLa cells induces formation of nuclear foci containing H2AFX and BRCA1 PubMed

Go to the HIV-1, Human Interaction Database

Pathways from PubChem

Go to the top of the page

Interactions

Go to the top of the page Help
Products Interactant Other Gene Complex Source Pubs Description

General gene information

Go to the top of the page Help

Markers

Homology

Gene Ontology Provided by GOA

Function Evidence Code Pubs
enables DNA binding TAS
Traceable Author Statement
more info
 PubMed 
enables DNA-binding transcription activator activity IEA
Inferred from Electronic Annotation
more info
  
enables RNA binding IDA
Inferred from Direct Assay
more info
 PubMed 
enables RNA polymerase binding IDA
Inferred from Direct Assay
more info
 PubMed 
enables damaged DNA binding IEA
Inferred from Electronic Annotation
more info
  
enables enzyme binding IPI
Inferred from Physical Interaction
more info
 PubMed 
enables histone H2AK127 ubiquitin ligase activity TAS
Traceable Author Statement
more info
 PubMed 
enables histone H2AK129 ubiquitin ligase activity TAS
Traceable Author Statement
more info
 PubMed 
enables identical protein binding IPI
Inferred from Physical Interaction
more info
 PubMed 
enables p53 binding IDA
Inferred from Direct Assay
more info
 PubMed 
enables protein binding IPI
Inferred from Physical Interaction
more info
 PubMed 
enables transcription cis-regulatory region binding IDA
Inferred from Direct Assay
more info
 PubMed 
enables transcription coactivator activity IDA
Inferred from Direct Assay
more info
 PubMed 
enables transcription coactivator activity IMP
Inferred from Mutant Phenotype
more info
 PubMed 
enables tubulin binding NAS
Non-traceable Author Statement
more info
 PubMed 
enables ubiquitin protein ligase binding IPI
Inferred from Physical Interaction
more info
 PubMed 
enables ubiquitin-modified histone reader activity TAS
Traceable Author Statement
more info
 PubMed 
enables ubiquitin-protein transferase activity IBA
Inferred from Biological aspect of Ancestor
more info
  
enables ubiquitin-protein transferase activity IDA
Inferred from Direct Assay
more info
 PubMed 
enables ubiquitin-protein transferase activity TAS
Traceable Author Statement
more info
  
enables zinc ion binding IEA
Inferred from Electronic Annotation
more info
  
Process Evidence Code Pubs
involved_in DNA damage response NAS
Non-traceable Author Statement
more info
 PubMed 
involved_in DNA repair NAS
Non-traceable Author Statement
more info
 PubMed 
involved_in DNA strand resection involved in replication fork processing NAS
Non-traceable Author Statement
more info
 PubMed 
involved_in cellular response to indole-3-methanol IDA
Inferred from Direct Assay
more info
 PubMed 
involved_in cellular response to ionizing radiation IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in cellular response to tumor necrosis factor IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in centrosome cycle IEA
Inferred from Electronic Annotation
more info
  
involved_in chordate embryonic development IBA
Inferred from Biological aspect of Ancestor
more info
  
involved_in chromatin remodeling TAS
Traceable Author Statement
more info
 PubMed 
involved_in chromosome segregation IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in double-strand break repair IDA
Inferred from Direct Assay
more info
 PubMed 
involved_in double-strand break repair IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in double-strand break repair TAS
Traceable Author Statement
more info
  
involved_in double-strand break repair via homologous recombination IBA
Inferred from Biological aspect of Ancestor
more info
  
involved_in double-strand break repair via homologous recombination IDA
Inferred from Direct Assay
more info
 PubMed 
involved_in fatty acid biosynthetic process IEA
Inferred from Electronic Annotation
more info
  
involved_in homologous recombination NAS
Non-traceable Author Statement
more info
 PubMed 
acts_upstream_of_or_within intrinsic apoptotic signaling pathway in response to DNA damage IDA
Inferred from Direct Assay
more info
 PubMed 
involved_in mitotic G2 DNA damage checkpoint signaling IBA
Inferred from Biological aspect of Ancestor
more info
  
involved_in mitotic G2 DNA damage checkpoint signaling IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in mitotic G2/M transition checkpoint NAS
Non-traceable Author Statement
more info
 PubMed 
involved_in negative regulation of DNA-templated transcription IDA
Inferred from Direct Assay
more info
 PubMed 
involved_in negative regulation of cell cycle NAS
Non-traceable Author Statement
more info
 PubMed 
involved_in negative regulation of cell growth IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in negative regulation of centriole replication NAS
Non-traceable Author Statement
more info
 PubMed 
involved_in negative regulation of extrinsic apoptotic signaling pathway via death domain receptors IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in negative regulation of fatty acid biosynthetic process IMP
Inferred from Mutant Phenotype
more info
 PubMed 
acts_upstream_of_positive_effect negative regulation of gene expression via chromosomal CpG island methylation IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in negative regulation of intracellular estrogen receptor signaling pathway IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in negative regulation of reactive oxygen species metabolic process IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in positive regulation of DNA repair IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in positive regulation of DNA-templated transcription IDA
Inferred from Direct Assay
more info
 PubMed 
involved_in positive regulation of DNA-templated transcription IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in positive regulation of angiogenesis IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in positive regulation of gene expression IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in positive regulation of transcription by RNA polymerase II IBA
Inferred from Biological aspect of Ancestor
more info
  
involved_in positive regulation of transcription by RNA polymerase II IDA
Inferred from Direct Assay
more info
 PubMed 
involved_in positive regulation of transcription by RNA polymerase II IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in positive regulation of vascular endothelial growth factor production IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in postreplication repair IDA
Inferred from Direct Assay
more info
 PubMed 
involved_in protein K6-linked ubiquitination IDA
Inferred from Direct Assay
more info
 PubMed 
involved_in protein autoubiquitination IDA
Inferred from Direct Assay
more info
 PubMed 
involved_in protein ubiquitination IDA
Inferred from Direct Assay
more info
 PubMed 
involved_in random inactivation of X chromosome IEA
Inferred from Electronic Annotation
more info
  
involved_in regulation of DNA damage checkpoint NAS
Non-traceable Author Statement
more info
 PubMed 
involved_in regulation of DNA repair NAS
Non-traceable Author Statement
more info
 PubMed 
acts_upstream_of regulation of cell cycle IDA
Inferred from Direct Assay
more info
 PubMed 
involved_in regulation of transcription by RNA polymerase II IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in response to ionizing radiation IMP
Inferred from Mutant Phenotype
more info
 PubMed 
involved_in sex-chromosome dosage compensation IBA
Inferred from Biological aspect of Ancestor
more info
  
Component Evidence Code Pubs
part_of BRCA1-A complex IBA
Inferred from Biological aspect of Ancestor
more info
  
part_of BRCA1-A complex IDA
Inferred from Direct Assay
more info
 PubMed 
part_of BRCA1-A complex NAS
Non-traceable Author Statement
more info
 PubMed 
part_of BRCA1-B complex IPI
Inferred from Physical Interaction
more info
 PubMed 
part_of BRCA1-BARD1 complex IBA
Inferred from Biological aspect of Ancestor
more info
  
part_of BRCA1-BARD1 complex IDA
Inferred from Direct Assay
more info
 PubMed 
part_of BRCA1-BARD1 complex IPI
Inferred from Physical Interaction
more info
 PubMed 
part_of BRCA1-C complex IPI
Inferred from Physical Interaction
more info
 PubMed 
part_of DNA repair complex IPI
Inferred from Physical Interaction
more info
 PubMed 
located_in XY body IEA
Inferred from Electronic Annotation
more info
  
located_in chromosome ISS
Inferred from Sequence or Structural Similarity
more info
  
located_in cytoplasm IDA
Inferred from Direct Assay
more info
 PubMed 
part_of gamma-tubulin ring complex NAS
Non-traceable Author Statement
more info
 PubMed 
is_active_in intracellular membraneless organelle IDA
Inferred from Direct Assay
more info
 PubMed 
located_in lateral element IDA
Inferred from Direct Assay
more info
 PubMed 
located_in male germ cell nucleus IEA
Inferred from Electronic Annotation
more info
  
located_in nuclear body IDA
Inferred from Direct Assay
more info
  
part_of nuclear ubiquitin ligase complex IDA
Inferred from Direct Assay
more info
 PubMed 
located_in nucleoplasm IDA
Inferred from Direct Assay
more info
  
located_in nucleoplasm TAS
Traceable Author Statement
more info
  
located_in nucleus IDA
Inferred from Direct Assay
more info
 PubMed 
located_in nucleus NAS
Non-traceable Author Statement
more info
 PubMed 
located_in plasma membrane IDA
Inferred from Direct Assay
more info
 PubMed 
part_of protein-containing complex IDA
Inferred from Direct Assay
more info
 PubMed 
part_of ribonucleoprotein complex IDA
Inferred from Direct Assay
more info
 PubMed 
part_of ubiquitin ligase complex NAS
Non-traceable Author Statement
more info
 PubMed 

General protein information

Go to the top of the page Help
Preferred Names
breast cancer type 1 susceptibility protein
Names
BRCA1/BRCA2-containing complex, subunit 1
Fanconi anemia, complementation group S
RING finger protein 53
breast and ovarian cancer susceptibility protein 1
breast cancer 1, early onset
early onset breast cancer 1
protein phosphatase 1, regulatory subunit 53
NP_001394500.1
NP_001394510.1
NP_001394511.1
NP_001394512.1
NP_001394514.1
NP_001394516.1
NP_001394519.1
NP_001394520.1
NP_001394522.1
NP_001394523.1
NP_001394525.1
NP_001394526.1
NP_001394527.1
NP_001394531.1
NP_001394532.1
NP_001394534.1
NP_001394539.1
NP_001394540.1
NP_001394541.1
NP_001394542.1
NP_001394543.1
NP_001394544.1
NP_001394545.1
NP_001394546.1
NP_001394547.1
NP_001394548.1
NP_001394549.1
NP_001394550.1
NP_001394551.1
NP_001394552.1
NP_001394553.1
NP_001394554.1
NP_001394555.1
NP_001394556.1
NP_001394557.1
NP_001394558.1
NP_001394559.1
NP_001394560.1
NP_001394561.1
NP_001394562.1
NP_001394563.1
NP_001394564.1
NP_001394565.1
NP_001394566.1
NP_001394567.1
NP_001394568.1
NP_001394569.1
NP_001394570.1
NP_001394571.1
NP_001394573.1
NP_001394574.1
NP_001394575.1
NP_001394576.1
NP_001394577.1
NP_001394578.1
NP_001394581.1
NP_001394582.1
NP_001394583.1
NP_001394584.1
NP_001394585.1
NP_001394586.1
NP_001394587.1
NP_001394588.1
NP_001394589.1
NP_001394590.1
NP_001394591.1
NP_001394592.1
NP_001394593.1
NP_001394594.1
NP_001394595.1
NP_001394596.1
NP_001394597.1
NP_001394598.1
NP_001394599.1
NP_001394600.1
NP_001394601.1
NP_001394602.1
NP_001394603.1
NP_001394604.1
NP_001394605.1
NP_001394606.1
NP_001394607.1
NP_001394608.1
NP_001394609.1
NP_001394610.1
NP_001394611.1
NP_001394612.1
NP_001394613.1
NP_001394614.1
NP_001394615.1
NP_001394616.1
NP_001394617.1
NP_001394618.1
NP_001394619.1
NP_001394620.1
NP_001394621.1
NP_001394623.1
NP_001394624.1
NP_001394625.1
NP_001394626.1
NP_001394627.1
NP_001394653.1
NP_001394654.1
NP_001394655.1
NP_001394656.1
NP_001394657.1
NP_001394658.1
NP_001394659.1
NP_001394660.1
NP_001394661.1
NP_001394662.1
NP_001394663.1
NP_001394664.1
NP_001394665.1
NP_001394666.1
NP_001394667.1
NP_001394668.1
NP_001394669.1
NP_001394670.1
NP_001394671.1
NP_001394672.1
NP_001394673.1
NP_001394674.1
NP_001394675.1
NP_001394676.1
NP_001394677.1
NP_001394678.1
NP_001394679.1
NP_001394680.1
NP_001394681.1
NP_001394767.1
NP_001394768.1
NP_001394770.1
NP_001394771.1
NP_001394772.1
NP_001394773.1
NP_001394774.1
NP_001394775.1
NP_001394776.1
NP_001394777.1
NP_001394778.1
NP_001394779.1
NP_001394780.1
NP_001394781.1
NP_001394782.1
NP_001394783.1
NP_001394787.1
NP_001394788.1
NP_001394789.1
NP_001394790.1
NP_001394791.1
NP_001394792.1
NP_001394803.1
NP_001394804.1
NP_001394808.1
NP_001394810.1
NP_001394811.1
NP_001394813.1
NP_001394814.1
NP_001394815.1
NP_001394816.1
NP_001394818.1
NP_001394823.1
NP_001394824.1
NP_001394825.1
NP_001394826.1
NP_001394827.1
NP_001394828.1
NP_001394829.1
NP_001394831.1
NP_001394833.1
NP_001394835.1
NP_001394836.1
NP_001394837.1
NP_001394838.1
NP_001394839.1
NP_001394844.1
NP_001394845.1
NP_001394846.1
NP_001394847.1
NP_001394848.1
NP_001394849.1
NP_001394850.1
NP_001394851.1
NP_001394852.1
NP_001394853.1
NP_001394854.1
NP_001394855.1
NP_001394856.1
NP_001394857.1
NP_001394858.1
NP_001394859.1
NP_001394860.1
NP_001394861.1
NP_001394862.1
NP_001394863.1
NP_001394864.1
NP_001394865.1
NP_001394866.1
NP_001394867.1
NP_001394868.1
NP_001394869.1
NP_001394870.1
NP_001394871.1
NP_001394872.1
NP_001394873.1
NP_001394874.1
NP_001394875.1
NP_001394876.1
NP_001394877.1
NP_001394878.1
NP_001394879.1
NP_001394880.1
NP_001394881.1
NP_001394882.1
NP_001394883.1
NP_001394884.1
NP_001394885.1
NP_001394886.1
NP_001394887.1
NP_001394888.1
NP_001394889.1
NP_001394891.1
NP_001394892.1
NP_001394893.1
NP_001394894.1
NP_001394895.1
NP_001394896.1
NP_001394897.1
NP_001394898.1
NP_001394899.1
NP_001394900.1
NP_001394901.1
NP_001394902.1
NP_001394903.1
NP_001394904.1
NP_001394905.1
NP_001394906.1
NP_001394907.1
NP_001394908.1
NP_001394909.1
NP_001394910.1
NP_001394911.1
NP_001394912.1
NP_001394913.1
NP_001394914.1
NP_001394915.1
NP_001394919.1
NP_001394920.1
NP_001394921.1
NP_001394922.1
NP_001395321.1
NP_001395325.1
NP_001395326.1
NP_001395327.1
NP_001395328.1
NP_001395329.1
NP_001395330.1
NP_001395331.1
NP_001395332.1
NP_001395333.1
NP_001395335.1
NP_001395336.1
NP_001395337.1
NP_001395338.1
NP_001395339.1
NP_001395340.1
NP_001395341.1
NP_001395342.1
NP_001395343.1
NP_001395344.1
NP_001395345.1
NP_001395347.1
NP_001395348.1
NP_001395349.1
NP_001395350.1
NP_001395351.1
NP_001395352.1
NP_001395353.1
NP_001395354.1
NP_001395355.1
NP_001395356.1
NP_001395357.1
NP_001395358.1
NP_001395359.1
NP_001395360.1
NP_001395361.1
NP_001395362.1
NP_001395363.1
NP_001395364.1
NP_001395365.1
NP_001395366.1
NP_001395367.1
NP_001395368.1
NP_001395369.1
NP_001395370.1
NP_001395371.1
NP_001395372.1
NP_001395373.1
NP_001395374.1
NP_001395375.1
NP_001395376.1
NP_001395377.1
NP_001395379.1
NP_001395380.1
NP_001395381.1
NP_001395382.1
NP_001395383.1
NP_001395384.1
NP_001395385.1
NP_001395386.1
NP_001395387.1
NP_001395388.1
NP_001395389.1
NP_001395390.1
NP_001395391.1
NP_001395392.1
NP_001395393.1
NP_001395394.1
NP_001395395.1
NP_001395396.1
NP_001395397.1
NP_001395398.1
NP_001395399.1
NP_001395401.1
NP_001395402.1
NP_001395403.1
NP_001395404.1
NP_001395405.1
NP_001395407.1
NP_001395408.1
NP_001395409.1
NP_001395410.1
NP_001395411.1
NP_001395412.1
NP_001395413.1
NP_001395414.1
NP_001395418.1
NP_001395419.1
NP_001395420.1
NP_001395421.1
NP_001395422.1
NP_001395423.1
NP_001395424.1
NP_001395425.1
NP_001395426.1
NP_001395427.1
NP_001395428.1
NP_001395429.1
NP_001395430.1
NP_001395431.1
NP_001395432.1
NP_001395433.1
NP_001395434.1
NP_001395435.1
NP_001395436.1
NP_001395437.1
NP_001395438.1
NP_001395439.1
NP_001395440.1
NP_001395441.1
NP_001395442.1
NP_001395443.1
NP_009225.1
NP_009228.2
NP_009229.2
NP_009230.2
NP_009231.2

NCBI Reference Sequences (RefSeq)

Go to the top of the page Help

NEW Try the new Transcript table

RefSeqs maintained independently of Annotated Genomes

These reference sequences exist independently of genome builds. Explain

These reference sequences are curated independently of the genome annotation cycle, so their versions may not match the RefSeq versions in the current genome build. Identify version mismatches by comparing the version of the RefSeq in this section to the one reported in Genomic regions, transcripts, and products above.

Genomic

  1. NG_005905.2 RefSeqGene

    Range
    92501..173689
    Download
    GenBank, FASTA, Sequence Viewer (Graphics), LRG_292

mRNA and Protein(s)

  1. NM_001407571.1 → NP_001394500.1  breast cancer type 1 susceptibility protein isoform 6

    Status: REVIEWED

    Source sequence(s)
    AC135721

  2. NM_001407581.1 → NP_001394510.1  breast cancer type 1 susceptibility protein isoform 7

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A2R8Y7V5
    Related
    ENSP00000496570.2, ENST00000644379.2

  3. NM_001407582.1 → NP_001394511.1  breast cancer type 1 susceptibility protein isoform 7

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A2R8Y7V5

  4. NM_001407583.1 → NP_001394512.1  breast cancer type 1 susceptibility protein isoform 2

    Status: REVIEWED

    Source sequence(s)
    AC135721

  5. NM_001407585.1 → NP_001394514.1  breast cancer type 1 susceptibility protein isoform 2

    Status: REVIEWED

    Source sequence(s)
    AC135721

  6. NM_001407587.1 → NP_001394516.1  breast cancer type 1 susceptibility protein isoform 8

    Status: REVIEWED

    Source sequence(s)
    AC135721

  7. NM_001407590.1 → NP_001394519.1  breast cancer type 1 susceptibility protein isoform 9

    Status: REVIEWED

    Source sequence(s)
    AC135721

  8. NM_001407591.1 → NP_001394520.1  breast cancer type 1 susceptibility protein isoform 9

    Status: REVIEWED

    Source sequence(s)
    AC135721

  9. NM_001407593.1 → NP_001394522.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9

  10. NM_001407594.1 → NP_001394523.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9
    Related
    ENSP00000478114.2, ENST00000618469.2

  11. NM_001407596.1 → NP_001394525.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9

  12. NM_001407597.1 → NP_001394526.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9
    Related
    ENSP00000419274.2, ENST00000470026.6

  13. NM_001407598.1 → NP_001394527.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9
    Related
    ENSP00000419103.2, ENST00000494123.6

  14. NM_001407602.1 → NP_001394531.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9

  15. NM_001407603.1 → NP_001394532.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9
    Related
    ENSP00000518978.1, ENST00000713676.1

  16. NM_001407605.1 → NP_001394534.1  breast cancer type 1 susceptibility protein isoform 1

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/Swiss-Prot
    E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9

  17. NM_001407610.1 → NP_001394539.1  breast cancer type 1 susceptibility protein isoform 10

    Status: REVIEWED

    Source sequence(s)
    AC135721

  18. NM_001407611.1 → NP_001394540.1  breast cancer type 1 susceptibility protein isoform 10

    Status: REVIEWED

    Source sequence(s)
    AC135721

  19. NM_001407612.1 → NP_001394541.1  breast cancer type 1 susceptibility protein isoform 10

    Status: REVIEWED

    Source sequence(s)
    AC135721

  20. NM_001407613.1 → NP_001394542.1  breast cancer type 1 susceptibility protein isoform 10

    Status: REVIEWED

    Source sequence(s)
    AC135721

  21. NM_001407614.1 → NP_001394543.1  breast cancer type 1 susceptibility protein isoform 10

    Status: REVIEWED

    Source sequence(s)
    AC135721

  22. NM_001407615.1 → NP_001394544.1  breast cancer type 1 susceptibility protein isoform 10

    Status: REVIEWED

    Source sequence(s)
    AC135721

  23. NM_001407616.1 → NP_001394545.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    H0Y850
    Related
    ENSP00000417241.2, ENST00000461574.2

  24. NM_001407617.1 → NP_001394546.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    H0Y850

  25. NM_001407618.1 → NP_001394547.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    H0Y850

  26. NM_001407619.1 → NP_001394548.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    H0Y850

  27. NM_001407620.1 → NP_001394549.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    H0Y850

  28. NM_001407621.1 → NP_001394550.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    H0Y850

  29. NM_001407622.1 → NP_001394551.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    H0Y850

  30. NM_001407623.1 → NP_001394552.1  breast cancer type 1 susceptibility protein isoform 11

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    H0Y850

  31. NM_001407624.1 → NP_001394553.1  breast cancer type 1 susceptibility protein isoform 12

    Status: REVIEWED

    Source sequence(s)
    AC135721

  32. NM_001407625.1 → NP_001394554.1  breast cancer type 1 susceptibility protein isoform 12

    Status: REVIEWED

    Source sequence(s)
    AC135721

  33. NM_001407626.1 → NP_001394555.1  breast cancer type 1 susceptibility protein isoform 12

    Status: REVIEWED

    Source sequence(s)
    AC135721

  34. NM_001407627.1 → NP_001394556.1  breast cancer type 1 susceptibility protein isoform 13

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    E7EQW4

  35. NM_001407628.1 → NP_001394557.1  breast cancer type 1 susceptibility protein isoform 13

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    E7EQW4
    Related
    ENSP00000417554.2, ENST00000476777.6

  36. NM_001407629.1 → NP_001394558.1  breast cancer type 1 susceptibility protein isoform 13

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    E7EQW4

  37. NM_001407630.1 → NP_001394559.1  breast cancer type 1 susceptibility protein isoform 13

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    E7EQW4

  38. NM_001407631.1 → NP_001394560.1  breast cancer type 1 susceptibility protein isoform 13

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    E7EQW4

  39. NM_001407632.1 → NP_001394561.1  breast cancer type 1 susceptibility protein isoform 13

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    E7EQW4

  40. NM_001407633.1 → NP_001394562.1  breast cancer type 1 susceptibility protein isoform 14

    Status: REVIEWED

    Source sequence(s)
    AC135721

  41. NM_001407634.1 → NP_001394563.1  breast cancer type 1 susceptibility protein isoform 14

    Status: REVIEWED

    Source sequence(s)
    AC135721

  42. NM_001407635.1 → NP_001394564.1  breast cancer type 1 susceptibility protein isoform 14

    Status: REVIEWED

    Source sequence(s)
    AC135721

  43. NM_001407636.1 → NP_001394565.1  breast cancer type 1 susceptibility protein isoform 14

    Status: REVIEWED

    Source sequence(s)
    AC135721

  44. NM_001407637.1 → NP_001394566.1  breast cancer type 1 susceptibility protein isoform 14

    Status: REVIEWED

    Source sequence(s)
    AC135721

  45. NM_001407638.1 → NP_001394567.1  breast cancer type 1 susceptibility protein isoform 14

    Status: REVIEWED

    Source sequence(s)
    AC135721

  46. NM_001407639.1 → NP_001394568.1  breast cancer type 1 susceptibility protein isoform 15

    Status: REVIEWED

    Source sequence(s)
    AC135721

  47. NM_001407640.1 → NP_001394569.1  breast cancer type 1 susceptibility protein isoform 15

    Status: REVIEWED

    Source sequence(s)
    AC135721

  48. NM_001407641.1 → NP_001394570.1  breast cancer type 1 susceptibility protein isoform 15

    Status: REVIEWED

    Source sequence(s)
    AC135721

  49. NM_001407642.1 → NP_001394571.1  breast cancer type 1 susceptibility protein isoform 15

    Status: REVIEWED

    Source sequence(s)
    AC135721

  50. NM_001407644.1 → NP_001394573.1  breast cancer type 1 susceptibility protein isoform 16

    Status: REVIEWED

    Source sequence(s)
    AC135721

  51. NM_001407645.1 → NP_001394574.1  breast cancer type 1 susceptibility protein isoform 16

    Status: REVIEWED

    Source sequence(s)
    AC135721

  52. NM_001407646.1 → NP_001394575.1  breast cancer type 1 susceptibility protein isoform 17

    Status: REVIEWED

    Source sequence(s)
    AC135721

  53. NM_001407647.1 → NP_001394576.1  breast cancer type 1 susceptibility protein isoform 18

    Status: REVIEWED

    Source sequence(s)
    AC135721

  54. NM_001407648.1 → NP_001394577.1  breast cancer type 1 susceptibility protein isoform 19

    Status: REVIEWED

    Source sequence(s)
    AC135721

  55. NM_001407649.1 → NP_001394578.1  breast cancer type 1 susceptibility protein isoform 20

    Status: REVIEWED

    Source sequence(s)
    AC135721

  56. NM_001407652.1 → NP_001394581.1  breast cancer type 1 susceptibility protein isoform 21

    Status: REVIEWED

    Source sequence(s)
    AC135721

  57. NM_001407653.1 → NP_001394582.1  breast cancer type 1 susceptibility protein isoform 22

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    E7ENB7, E9PH68
    Related
    ENSP00000419988.2, ENST00000477152.6

  58. NM_001407654.1 → NP_001394583.1  breast cancer type 1 susceptibility protein isoform 22

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    E7ENB7, E9PH68

  59. NM_001407655.1 → NP_001394584.1  breast cancer type 1 susceptibility protein isoform 22

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    E7ENB7, E9PH68

  60. NM_001407656.1 → NP_001394585.1  breast cancer type 1 susceptibility protein isoform 23

    Status: REVIEWED

    Source sequence(s)
    AC135721

  61. NM_001407657.1 → NP_001394586.1  breast cancer type 1 susceptibility protein isoform 24

    Status: REVIEWED

    Source sequence(s)
    AC135721

  62. NM_001407658.1 → NP_001394587.1  breast cancer type 1 susceptibility protein isoform 24

    Status: REVIEWED

    Source sequence(s)
    AC135721

  63. NM_001407659.1 → NP_001394588.1  breast cancer type 1 susceptibility protein isoform 25

    Status: REVIEWED

    Source sequence(s)
    AC135721

  64. NM_001407660.1 → NP_001394589.1  breast cancer type 1 susceptibility protein isoform 25

    Status: REVIEWED

    Source sequence(s)
    AC135721

  65. NM_001407661.1 → NP_001394590.1  breast cancer type 1 susceptibility protein isoform 26

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQD3

  66. NM_001407662.1 → NP_001394591.1  breast cancer type 1 susceptibility protein isoform 26

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQD3

  67. NM_001407663.1 → NP_001394592.1  breast cancer type 1 susceptibility protein isoform 93

    Status: REVIEWED

    Source sequence(s)
    AC135721

  68. NM_001407664.1 → NP_001394593.1  breast cancer type 1 susceptibility protein isoform 27

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A0U1RRA9

  69. NM_001407665.1 → NP_001394594.1  breast cancer type 1 susceptibility protein isoform 27

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A0U1RRA9

  70. NM_001407666.1 → NP_001394595.1  breast cancer type 1 susceptibility protein isoform 27

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A0U1RRA9

  71. NM_001407667.1 → NP_001394596.1  breast cancer type 1 susceptibility protein isoform 27

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A0U1RRA9
    Related
    ENSP00000489431.2, ENST00000634433.2

  72. NM_001407668.1 → NP_001394597.1  breast cancer type 1 susceptibility protein isoform 27

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A0U1RRA9

  73. NM_001407669.1 → NP_001394598.1  breast cancer type 1 susceptibility protein isoform 27

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A0U1RRA9

  74. NM_001407670.1 → NP_001394599.1  breast cancer type 1 susceptibility protein isoform 28

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    H0Y8D8
    Related
    ENSP00000420201.2, ENST00000473961.6

  75. NM_001407671.1 → NP_001394600.1  breast cancer type 1 susceptibility protein isoform 28

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    H0Y8D8

  76. NM_001407672.1 → NP_001394601.1  breast cancer type 1 susceptibility protein isoform 28

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    H0Y8D8

  77. NM_001407673.1 → NP_001394602.1  breast cancer type 1 susceptibility protein isoform 28

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    H0Y8D8

  78. NM_001407674.1 → NP_001394603.1  breast cancer type 1 susceptibility protein isoform 29

    Status: REVIEWED

    Source sequence(s)
    AC135721

  79. NM_001407675.1 → NP_001394604.1  breast cancer type 1 susceptibility protein isoform 29

    Status: REVIEWED

    Source sequence(s)
    AC135721

  80. NM_001407676.1 → NP_001394605.1  breast cancer type 1 susceptibility protein isoform 29

    Status: REVIEWED

    Source sequence(s)
    AC135721

  81. NM_001407677.1 → NP_001394606.1  breast cancer type 1 susceptibility protein isoform 30

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQJ6

  82. NM_001407678.1 → NP_001394607.1  breast cancer type 1 susceptibility protein isoform 30

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQJ6

  83. NM_001407679.1 → NP_001394608.1  breast cancer type 1 susceptibility protein isoform 30

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQJ6

  84. NM_001407680.1 → NP_001394609.1  breast cancer type 1 susceptibility protein isoform 30

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQJ6

  85. NM_001407681.1 → NP_001394610.1  breast cancer type 1 susceptibility protein isoform 31

    Status: REVIEWED

    Source sequence(s)
    AC135721

  86. NM_001407682.1 → NP_001394611.1  breast cancer type 1 susceptibility protein isoform 31

    Status: REVIEWED

    Source sequence(s)
    AC135721

  87. NM_001407683.1 → NP_001394612.1  breast cancer type 1 susceptibility protein isoform 31

    Status: REVIEWED

    Source sequence(s)
    AC135721

  88. NM_001407684.1 → NP_001394613.1  breast cancer type 1 susceptibility protein isoform 32

    Status: REVIEWED

    Source sequence(s)
    AC135721

  89. NM_001407685.1 → NP_001394614.1  breast cancer type 1 susceptibility protein isoform 33

    Status: REVIEWED

    Source sequence(s)
    AC135721

  90. NM_001407686.1 → NP_001394615.1  breast cancer type 1 susceptibility protein isoform 33

    Status: REVIEWED

    Source sequence(s)
    AC135721

  91. NM_001407687.1 → NP_001394616.1  breast cancer type 1 susceptibility protein isoform 33

    Status: REVIEWED

    Source sequence(s)
    AC135721

  92. NM_001407688.1 → NP_001394617.1  breast cancer type 1 susceptibility protein isoform 34

    Status: REVIEWED

    Source sequence(s)
    AC135721

  93. NM_001407689.1 → NP_001394618.1  breast cancer type 1 susceptibility protein isoform 34

    Status: REVIEWED

    Source sequence(s)
    AC135721

  94. NM_001407690.1 → NP_001394619.1  breast cancer type 1 susceptibility protein isoform 35

    Status: REVIEWED

    Source sequence(s)
    AC135721

  95. NM_001407691.1 → NP_001394620.1  breast cancer type 1 susceptibility protein isoform 35

    Status: REVIEWED

    Source sequence(s)
    AC135721

  96. NM_001407692.1 → NP_001394621.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK3

  97. NM_001407694.1 → NP_001394623.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK3

  98. NM_001407695.1 → NP_001394624.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK3

  99. NM_001407696.1 → NP_001394625.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK3

  100. NM_001407697.1 → NP_001394626.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK3

  101. NM_001407698.1 → NP_001394627.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK3

  102. NM_001407724.1 → NP_001394653.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK3

  103. NM_001407725.1 → NP_001394654.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK3

  104. NM_001407726.1 → NP_001394655.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK3

  105. NM_001407727.1 → NP_001394656.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK3

  106. NM_001407728.1 → NP_001394657.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK3

  107. NM_001407729.1 → NP_001394658.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK3

  108. NM_001407730.1 → NP_001394659.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK3
    Related
    ENSP00000498906.2, ENST00000652672.2

  109. NM_001407731.1 → NP_001394660.1  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK3

  110. NM_001407732.1 → NP_001394661.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721

  111. NM_001407733.1 → NP_001394662.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721

  112. NM_001407734.1 → NP_001394663.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721

  113. NM_001407735.1 → NP_001394664.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721

  114. NM_001407736.1 → NP_001394665.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721

  115. NM_001407737.1 → NP_001394666.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721

  116. NM_001407738.1 → NP_001394667.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721

  117. NM_001407739.1 → NP_001394668.1  breast cancer type 1 susceptibility protein isoform 36

    Status: REVIEWED

    Source sequence(s)
    AC135721

  118. NM_001407740.1 → NP_001394669.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK7

  119. NM_001407741.1 → NP_001394670.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK7

  120. NM_001407742.1 → NP_001394671.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK7

  121. NM_001407743.1 → NP_001394672.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK7

  122. NM_001407744.1 → NP_001394673.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK7

  123. NM_001407745.1 → NP_001394674.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK7

  124. NM_001407746.1 → NP_001394675.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK7

  125. NM_001407747.1 → NP_001394676.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK7

  126. NM_001407748.1 → NP_001394677.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK7

  127. NM_001407749.1 → NP_001394678.1  breast cancer type 1 susceptibility protein isoform 37

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQK7

  128. NM_001407750.1 → NP_001394679.1  breast cancer type 1 susceptibility protein isoform 38

    Status: REVIEWED

    Source sequence(s)
    AC135721

  129. NM_001407751.1 → NP_001394680.1  breast cancer type 1 susceptibility protein isoform 38

    Status: REVIEWED

    Source sequence(s)
    AC135721

  130. NM_001407752.1 → NP_001394681.1  breast cancer type 1 susceptibility protein isoform 38

    Status: REVIEWED

    Source sequence(s)
    AC135721

  131. NM_001407838.1 → NP_001394767.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721

  132. NM_001407839.1 → NP_001394768.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721

  133. NM_001407841.1 → NP_001394770.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721

  134. NM_001407842.1 → NP_001394771.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721

  135. NM_001407843.1 → NP_001394772.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721

  136. NM_001407844.1 → NP_001394773.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721

  137. NM_001407845.1 → NP_001394774.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721

  138. NM_001407846.1 → NP_001394775.1  breast cancer type 1 susceptibility protein isoform 39

    Status: REVIEWED

    Source sequence(s)
    AC135721

  139. NM_001407847.1 → NP_001394776.1  breast cancer type 1 susceptibility protein isoform 40

    Status: REVIEWED

    Source sequence(s)
    AC135721

  140. NM_001407848.1 → NP_001394777.1  breast cancer type 1 susceptibility protein isoform 40

    Status: REVIEWED

    Source sequence(s)
    AC135721

  141. NM_001407849.1 → NP_001394778.1  breast cancer type 1 susceptibility protein isoform 40

    Status: REVIEWED

    Source sequence(s)
    AC135721

  142. NM_001407850.1 → NP_001394779.1  breast cancer type 1 susceptibility protein isoform 41

    Status: REVIEWED

    Source sequence(s)
    AC135721

  143. NM_001407851.1 → NP_001394780.1  breast cancer type 1 susceptibility protein isoform 41

    Status: REVIEWED

    Source sequence(s)
    AC135721

  144. NM_001407852.1 → NP_001394781.1  breast cancer type 1 susceptibility protein isoform 41

    Status: REVIEWED

    Source sequence(s)
    AC135721

  145. NM_001407853.1 → NP_001394782.1  breast cancer type 1 susceptibility protein isoform 42

    Status: REVIEWED

    Source sequence(s)
    AC135721

  146. NM_001407854.1 → NP_001394783.1  breast cancer type 1 susceptibility protein isoform 43

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QPY6

  147. NM_001407858.1 → NP_001394787.1  breast cancer type 1 susceptibility protein isoform 44

    Status: REVIEWED

    Source sequence(s)
    AC135721

  148. NM_001407859.1 → NP_001394788.1  breast cancer type 1 susceptibility protein isoform 44

    Status: REVIEWED

    Source sequence(s)
    AC135721

  149. NM_001407860.1 → NP_001394789.1  breast cancer type 1 susceptibility protein isoform 45

    Status: REVIEWED

    Source sequence(s)
    AC135721

  150. NM_001407861.1 → NP_001394790.1  breast cancer type 1 susceptibility protein isoform 46

    Status: REVIEWED

    Source sequence(s)
    AC135721

  151. NM_001407862.1 → NP_001394791.1  breast cancer type 1 susceptibility protein isoform 47

    Status: REVIEWED

    Source sequence(s)
    AC135721

  152. NM_001407863.1 → NP_001394792.1  breast cancer type 1 susceptibility protein isoform 48

    Status: REVIEWED

    Source sequence(s)
    AC135721

  153. NM_001407874.1 → NP_001394803.1  breast cancer type 1 susceptibility protein isoform 49

    Status: REVIEWED

    Source sequence(s)
    AC135721

  154. NM_001407875.1 → NP_001394804.1  breast cancer type 1 susceptibility protein isoform 49

    Status: REVIEWED

    Source sequence(s)
    AC135721

  155. NM_001407879.1 → NP_001394808.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721

  156. NM_001407881.1 → NP_001394810.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721

  157. NM_001407882.1 → NP_001394811.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721

  158. NM_001407884.1 → NP_001394813.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721

  159. NM_001407885.1 → NP_001394814.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721

  160. NM_001407886.1 → NP_001394815.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721

  161. NM_001407887.1 → NP_001394816.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721

  162. NM_001407889.1 → NP_001394818.1  breast cancer type 1 susceptibility protein isoform 50

    Status: REVIEWED

    Source sequence(s)
    AC135721

  163. NM_001407894.1 → NP_001394823.1  breast cancer type 1 susceptibility protein isoform 6

    Status: REVIEWED

    Source sequence(s)
    AC135721

  164. NM_001407895.1 → NP_001394824.1  breast cancer type 1 susceptibility protein isoform 6

    Status: REVIEWED

    Source sequence(s)
    AC135721

  165. NM_001407896.1 → NP_001394825.1  breast cancer type 1 susceptibility protein isoform 6

    Status: REVIEWED

    Source sequence(s)
    AC135721

  166. NM_001407897.1 → NP_001394826.1  breast cancer type 1 susceptibility protein isoform 6

    Status: REVIEWED

    Source sequence(s)
    AC135721

  167. NM_001407898.1 → NP_001394827.1  breast cancer type 1 susceptibility protein isoform 6

    Status: REVIEWED

    Source sequence(s)
    AC135721

  168. NM_001407899.1 → NP_001394828.1  breast cancer type 1 susceptibility protein isoform 6

    Status: REVIEWED

    Source sequence(s)
    AC135721

  169. NM_001407900.1 → NP_001394829.1  breast cancer type 1 susceptibility protein isoform 52

    Status: REVIEWED

    Source sequence(s)
    AC135721

  170. NM_001407902.1 → NP_001394831.1  breast cancer type 1 susceptibility protein isoform 52

    Status: REVIEWED

    Source sequence(s)
    AC135721

  171. NM_001407904.1 → NP_001394833.1  breast cancer type 1 susceptibility protein isoform 52

    Status: REVIEWED

    Source sequence(s)
    AC135721

  172. NM_001407906.1 → NP_001394835.1  breast cancer type 1 susceptibility protein isoform 52

    Status: REVIEWED

    Source sequence(s)
    AC135721

  173. NM_001407907.1 → NP_001394836.1  breast cancer type 1 susceptibility protein isoform 53

    Status: REVIEWED

    Source sequence(s)
    AC135721

  174. NM_001407908.1 → NP_001394837.1  breast cancer type 1 susceptibility protein isoform 53

    Status: REVIEWED

    Source sequence(s)
    AC135721

  175. NM_001407909.1 → NP_001394838.1  breast cancer type 1 susceptibility protein isoform 53

    Status: REVIEWED

    Source sequence(s)
    AC135721

  176. NM_001407910.1 → NP_001394839.1  breast cancer type 1 susceptibility protein isoform 53

    Status: REVIEWED

    Source sequence(s)
    AC135721

  177. NM_001407915.1 → NP_001394844.1  breast cancer type 1 susceptibility protein isoform 54

    Status: REVIEWED

    Source sequence(s)
    AC135721

  178. NM_001407916.1 → NP_001394845.1  breast cancer type 1 susceptibility protein isoform 55

    Status: REVIEWED

    Source sequence(s)
    AC135721

  179. NM_001407917.1 → NP_001394846.1  breast cancer type 1 susceptibility protein isoform 55

    Status: REVIEWED

    Source sequence(s)
    AC135721

  180. NM_001407918.1 → NP_001394847.1  breast cancer type 1 susceptibility protein isoform 55

    Status: REVIEWED

    Source sequence(s)
    AC135721

  181. NM_001407919.1 → NP_001394848.1  breast cancer type 1 susceptibility protein isoform 56

    Status: REVIEWED

    Source sequence(s)
    AC135721

  182. NM_001407920.1 → NP_001394849.1  breast cancer type 1 susceptibility protein isoform 57

    Status: REVIEWED

    Source sequence(s)
    AC135721

  183. NM_001407921.1 → NP_001394850.1  breast cancer type 1 susceptibility protein isoform 57

    Status: REVIEWED

    Source sequence(s)
    AC135721

  184. NM_001407922.1 → NP_001394851.1  breast cancer type 1 susceptibility protein isoform 57

    Status: REVIEWED

    Source sequence(s)
    AC135721

  185. NM_001407923.1 → NP_001394852.1  breast cancer type 1 susceptibility protein isoform 57

    Status: REVIEWED

    Source sequence(s)
    AC135721

  186. NM_001407924.1 → NP_001394853.1  breast cancer type 1 susceptibility protein isoform 57

    Status: REVIEWED

    Source sequence(s)
    AC135721

  187. NM_001407925.1 → NP_001394854.1  breast cancer type 1 susceptibility protein isoform 57

    Status: REVIEWED

    Source sequence(s)
    AC135721

  188. NM_001407926.1 → NP_001394855.1  breast cancer type 1 susceptibility protein isoform 57

    Status: REVIEWED

    Source sequence(s)
    AC135721

  189. NM_001407927.1 → NP_001394856.1  breast cancer type 1 susceptibility protein isoform 58

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1VR53

  190. NM_001407928.1 → NP_001394857.1  breast cancer type 1 susceptibility protein isoform 58

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1VR53

  191. NM_001407929.1 → NP_001394858.1  breast cancer type 1 susceptibility protein isoform 58

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1VR53

  192. NM_001407930.1 → NP_001394859.1  breast cancer type 1 susceptibility protein isoform 59

    Status: REVIEWED

    Source sequence(s)
    AC135721

  193. NM_001407931.1 → NP_001394860.1  breast cancer type 1 susceptibility protein isoform 59

    Status: REVIEWED

    Source sequence(s)
    AC135721

  194. NM_001407932.1 → NP_001394861.1  breast cancer type 1 susceptibility protein isoform 59

    Status: REVIEWED

    Source sequence(s)
    AC135721

  195. NM_001407933.1 → NP_001394862.1  breast cancer type 1 susceptibility protein isoform 60

    Status: REVIEWED

    Source sequence(s)
    AC135721

  196. NM_001407934.1 → NP_001394863.1  breast cancer type 1 susceptibility protein isoform 61

    Status: REVIEWED

    Source sequence(s)
    AC135721

  197. NM_001407935.1 → NP_001394864.1  breast cancer type 1 susceptibility protein isoform 62

    Status: REVIEWED

    Source sequence(s)
    AC135721

  198. NM_001407936.1 → NP_001394865.1  breast cancer type 1 susceptibility protein isoform 63

    Status: REVIEWED

    Source sequence(s)
    AC135721

  199. NM_001407937.1 → NP_001394866.1  breast cancer type 1 susceptibility protein isoform 64

    Status: REVIEWED

    Source sequence(s)
    AC135721

  200. NM_001407938.1 → NP_001394867.1  breast cancer type 1 susceptibility protein isoform 64

    Status: REVIEWED

    Source sequence(s)
    AC135721

  201. NM_001407939.1 → NP_001394868.1  breast cancer type 1 susceptibility protein isoform 65

    Status: REVIEWED

    Source sequence(s)
    AC135721

  202. NM_001407940.1 → NP_001394869.1  breast cancer type 1 susceptibility protein isoform 66

    Status: REVIEWED

    Source sequence(s)
    AC135721

  203. NM_001407941.1 → NP_001394870.1  breast cancer type 1 susceptibility protein isoform 67

    Status: REVIEWED

    Source sequence(s)
    AC135721

  204. NM_001407942.1 → NP_001394871.1  breast cancer type 1 susceptibility protein isoform 68

    Status: REVIEWED

    Source sequence(s)
    AC135721

  205. NM_001407943.1 → NP_001394872.1  breast cancer type 1 susceptibility protein isoform 69

    Status: REVIEWED

    Source sequence(s)
    AC135721

  206. NM_001407944.1 → NP_001394873.1  breast cancer type 1 susceptibility protein isoform 70

    Status: REVIEWED

    Source sequence(s)
    AC135721

  207. NM_001407945.1 → NP_001394874.1  breast cancer type 1 susceptibility protein isoform 70

    Status: REVIEWED

    Source sequence(s)
    AC135721

  208. NM_001407946.1 → NP_001394875.1  breast cancer type 1 susceptibility protein isoform 71

    Status: REVIEWED

    Source sequence(s)
    AC135721

  209. NM_001407947.1 → NP_001394876.1  breast cancer type 1 susceptibility protein isoform 71

    Status: REVIEWED

    Source sequence(s)
    AC135721

  210. NM_001407948.1 → NP_001394877.1  breast cancer type 1 susceptibility protein isoform 71

    Status: REVIEWED

    Source sequence(s)
    AC135721

  211. NM_001407949.1 → NP_001394878.1  breast cancer type 1 susceptibility protein isoform 71

    Status: REVIEWED

    Source sequence(s)
    AC135721

  212. NM_001407950.1 → NP_001394879.1  breast cancer type 1 susceptibility protein isoform 72

    Status: REVIEWED

    Source sequence(s)
    AC135721

  213. NM_001407951.1 → NP_001394880.1  breast cancer type 1 susceptibility protein isoform 72

    Status: REVIEWED

    Source sequence(s)
    AC135721

  214. NM_001407952.1 → NP_001394881.1  breast cancer type 1 susceptibility protein isoform 73

    Status: REVIEWED

    Source sequence(s)
    AC135721

  215. NM_001407953.1 → NP_001394882.1  breast cancer type 1 susceptibility protein isoform 73

    Status: REVIEWED

    Source sequence(s)
    AC135721

  216. NM_001407954.1 → NP_001394883.1  breast cancer type 1 susceptibility protein isoform 74

    Status: REVIEWED

    Source sequence(s)
    AC135721

  217. NM_001407955.1 → NP_001394884.1  breast cancer type 1 susceptibility protein isoform 74

    Status: REVIEWED

    Source sequence(s)
    AC135721

  218. NM_001407956.1 → NP_001394885.1  breast cancer type 1 susceptibility protein isoform 75

    Status: REVIEWED

    Source sequence(s)
    AC135721

  219. NM_001407957.1 → NP_001394886.1  breast cancer type 1 susceptibility protein isoform 76

    Status: REVIEWED

    Source sequence(s)
    AC135721

  220. NM_001407958.1 → NP_001394887.1  breast cancer type 1 susceptibility protein isoform 77

    Status: REVIEWED

    Source sequence(s)
    AC135721

  221. NM_001407959.1 → NP_001394888.1  breast cancer type 1 susceptibility protein isoform 78

    Status: REVIEWED

    Source sequence(s)
    AC135721

  222. NM_001407960.1 → NP_001394889.1  breast cancer type 1 susceptibility protein isoform 79

    Status: REVIEWED

    Source sequence(s)
    AC135721

  223. NM_001407962.1 → NP_001394891.1  breast cancer type 1 susceptibility protein isoform 80

    Status: REVIEWED

    Source sequence(s)
    AC135721

  224. NM_001407963.1 → NP_001394892.1  breast cancer type 1 susceptibility protein isoform 81

    Status: REVIEWED

    Source sequence(s)
    AC135721

  225. NM_001407964.1 → NP_001394893.1  breast cancer type 1 susceptibility protein isoform 82

    Status: REVIEWED

    Source sequence(s)
    AC135721

  226. NM_001407965.1 → NP_001394894.1  breast cancer type 1 susceptibility protein isoform 83

    Status: REVIEWED

    Source sequence(s)
    AC135721

  227. NM_001407966.1 → NP_001394895.1  breast cancer type 1 susceptibility protein isoform 84

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    C9IZW4
    Related
    ENSP00000418986.2, ENST00000497488.2

  228. NM_001407967.1 → NP_001394896.1  breast cancer type 1 susceptibility protein isoform 85

    Status: REVIEWED

    Source sequence(s)
    AC135721

  229. NM_001407968.1 → NP_001394897.1  breast cancer type 1 susceptibility protein isoform 86

    Status: REVIEWED

    Source sequence(s)
    AC135721

  230. NM_001407969.1 → NP_001394898.1  breast cancer type 1 susceptibility protein isoform 87

    Status: REVIEWED

    Source sequence(s)
    AC135721

  231. NM_001407970.1 → NP_001394899.1  breast cancer type 1 susceptibility protein isoform 88

    Status: REVIEWED

    Source sequence(s)
    AC135721

  232. NM_001407971.1 → NP_001394900.1  breast cancer type 1 susceptibility protein isoform 88

    Status: REVIEWED

    Source sequence(s)
    AC135721

  233. NM_001407972.1 → NP_001394901.1  breast cancer type 1 susceptibility protein isoform 89

    Status: REVIEWED

    Source sequence(s)
    AC135721

  234. NM_001407973.1 → NP_001394902.1  breast cancer type 1 susceptibility protein isoform 90

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1VVE2

  235. NM_001407974.1 → NP_001394903.1  breast cancer type 1 susceptibility protein isoform 90

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1VVE2

  236. NM_001407975.1 → NP_001394904.1  breast cancer type 1 susceptibility protein isoform 90

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1VVE2

  237. NM_001407976.1 → NP_001394905.1  breast cancer type 1 susceptibility protein isoform 90

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1VVE2

  238. NM_001407977.1 → NP_001394906.1  breast cancer type 1 susceptibility protein isoform 90

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1VVE2

  239. NM_001407978.1 → NP_001394907.1  breast cancer type 1 susceptibility protein isoform 90

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1VVE2

  240. NM_001407979.1 → NP_001394908.1  breast cancer type 1 susceptibility protein isoform 91

    Status: REVIEWED

    Source sequence(s)
    AC135721

  241. NM_001407980.1 → NP_001394909.1  breast cancer type 1 susceptibility protein isoform 91

    Status: REVIEWED

    Source sequence(s)
    AC135721

  242. NM_001407981.1 → NP_001394910.1  breast cancer type 1 susceptibility protein isoform 91

    Status: REVIEWED

    Source sequence(s)
    AC135721

  243. NM_001407982.1 → NP_001394911.1  breast cancer type 1 susceptibility protein isoform 91

    Status: REVIEWED

    Source sequence(s)
    AC135721

  244. NM_001407983.1 → NP_001394912.1  breast cancer type 1 susceptibility protein isoform 91

    Status: REVIEWED

    Source sequence(s)
    AC135721

  245. NM_001407984.1 → NP_001394913.1  breast cancer type 1 susceptibility protein isoform 92

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    E7EUM2

  246. NM_001407985.1 → NP_001394914.1  breast cancer type 1 susceptibility protein isoform 92

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    E7EUM2
    Related
    ENSP00000420412.2, ENST00000478531.6

  247. NM_001407986.1 → NP_001394915.1  breast cancer type 1 susceptibility protein isoform 92

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    E7EUM2

  248. NM_001407990.1 → NP_001394919.1  breast cancer type 1 susceptibility protein isoform 91

    Status: REVIEWED

    Source sequence(s)
    AC135721

  249. NM_001407991.1 → NP_001394920.1  breast cancer type 1 susceptibility protein isoform 92

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    E7EUM2

  250. NM_001407992.1 → NP_001394921.1  breast cancer type 1 susceptibility protein isoform 92

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    E7EUM2

  251. NM_001407993.1 → NP_001394922.1  breast cancer type 1 susceptibility protein isoform 4

    Status: REVIEWED

    Source sequence(s)
    AC135721
    Related
    ENSP00000420705.2, ENST00000491747.6

  252. NM_001408392.1 → NP_001395321.1  breast cancer type 1 susceptibility protein isoform 94

    Status: REVIEWED

    Source sequence(s)
    AC135721

  253. NM_001408396.1 → NP_001395325.1  breast cancer type 1 susceptibility protein isoform 94

    Status: REVIEWED

    Source sequence(s)
    AC135721

  254. NM_001408397.1 → NP_001395326.1  breast cancer type 1 susceptibility protein isoform 94

    Status: REVIEWED

    Source sequence(s)
    AC135721

  255. NM_001408398.1 → NP_001395327.1  breast cancer type 1 susceptibility protein isoform 94

    Status: REVIEWED

    Source sequence(s)
    AC135721

  256. NM_001408399.1 → NP_001395328.1  breast cancer type 1 susceptibility protein isoform 94

    Status: REVIEWED

    Source sequence(s)
    AC135721

  257. NM_001408400.1 → NP_001395329.1  breast cancer type 1 susceptibility protein isoform 95

    Status: REVIEWED

    Source sequence(s)
    AC135721

  258. NM_001408401.1 → NP_001395330.1  breast cancer type 1 susceptibility protein isoform 95

    Status: REVIEWED

    Source sequence(s)
    AC135721

  259. NM_001408402.1 → NP_001395331.1  breast cancer type 1 susceptibility protein isoform 95

    Status: REVIEWED

    Source sequence(s)
    AC135721

  260. NM_001408403.1 → NP_001395332.1  breast cancer type 1 susceptibility protein isoform 96

    Status: REVIEWED

    Source sequence(s)
    AC135721

  261. NM_001408404.1 → NP_001395333.1  breast cancer type 1 susceptibility protein isoform 96

    Status: REVIEWED

    Source sequence(s)
    AC135721

  262. NM_001408406.1 → NP_001395335.1  breast cancer type 1 susceptibility protein isoform 97

    Status: REVIEWED

    Source sequence(s)
    AC135721

  263. NM_001408407.1 → NP_001395336.1  breast cancer type 1 susceptibility protein isoform 98

    Status: REVIEWED

    Source sequence(s)
    AC135721

  264. NM_001408408.1 → NP_001395337.1  breast cancer type 1 susceptibility protein isoform 99

    Status: REVIEWED

    Source sequence(s)
    AC135721

  265. NM_001408409.1 → NP_001395338.1  breast cancer type 1 susceptibility protein isoform 100

    Status: REVIEWED

    Source sequence(s)
    AC135721

  266. NM_001408410.1 → NP_001395339.1  breast cancer type 1 susceptibility protein isoform 101

    Status: REVIEWED

    Source sequence(s)
    AC135721

  267. NM_001408411.1 → NP_001395340.1  breast cancer type 1 susceptibility protein isoform 102

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1VVD0

  268. NM_001408412.1 → NP_001395341.1  breast cancer type 1 susceptibility protein isoform 103

    Status: REVIEWED

    Source sequence(s)
    AC135721

  269. NM_001408413.1 → NP_001395342.1  breast cancer type 1 susceptibility protein isoform 104

    Status: REVIEWED

    Source sequence(s)
    AC135721

  270. NM_001408414.1 → NP_001395343.1  breast cancer type 1 susceptibility protein isoform 103

    Status: REVIEWED

    Source sequence(s)
    AC135721

  271. NM_001408415.1 → NP_001395344.1  breast cancer type 1 susceptibility protein isoform 103

    Status: REVIEWED

    Source sequence(s)
    AC135721

  272. NM_001408416.1 → NP_001395345.1  breast cancer type 1 susceptibility protein isoform 104

    Status: REVIEWED

    Source sequence(s)
    AC135721

  273. NM_001408418.1 → NP_001395347.1  breast cancer type 1 susceptibility protein isoform 105

    Status: REVIEWED

    Source sequence(s)
    AC135721

  274. NM_001408419.1 → NP_001395348.1  breast cancer type 1 susceptibility protein isoform 105

    Status: REVIEWED

    Source sequence(s)
    AC135721
    Related
    ENSP00000312236.5, ENST00000352993.7

  275. NM_001408420.1 → NP_001395349.1  breast cancer type 1 susceptibility protein isoform 105

    Status: REVIEWED

    Source sequence(s)
    AC135721

  276. NM_001408421.1 → NP_001395350.1  breast cancer type 1 susceptibility protein isoform 106

    Status: REVIEWED

    Source sequence(s)
    AC135721

  277. NM_001408422.1 → NP_001395351.1  breast cancer type 1 susceptibility protein isoform 107

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QPR4

  278. NM_001408423.1 → NP_001395352.1  breast cancer type 1 susceptibility protein isoform 107

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QPR4

  279. NM_001408424.1 → NP_001395353.1  breast cancer type 1 susceptibility protein isoform 106

    Status: REVIEWED

    Source sequence(s)
    AC135721

  280. NM_001408425.1 → NP_001395354.1  breast cancer type 1 susceptibility protein isoform 108

    Status: REVIEWED

    Source sequence(s)
    AC135721

  281. NM_001408426.1 → NP_001395355.1  breast cancer type 1 susceptibility protein isoform 108

    Status: REVIEWED

    Source sequence(s)
    AC135721

  282. NM_001408427.1 → NP_001395356.1  breast cancer type 1 susceptibility protein isoform 108

    Status: REVIEWED

    Source sequence(s)
    AC135721

  283. NM_001408428.1 → NP_001395357.1  breast cancer type 1 susceptibility protein isoform 108

    Status: REVIEWED

    Source sequence(s)
    AC135721

  284. NM_001408429.1 → NP_001395358.1  breast cancer type 1 susceptibility protein isoform 108

    Status: REVIEWED

    Source sequence(s)
    AC135721

  285. NM_001408430.1 → NP_001395359.1  breast cancer type 1 susceptibility protein isoform 108

    Status: REVIEWED

    Source sequence(s)
    AC135721

  286. NM_001408431.1 → NP_001395360.1  breast cancer type 1 susceptibility protein isoform 109

    Status: REVIEWED

    Source sequence(s)
    AC135721

  287. NM_001408432.1 → NP_001395361.1  breast cancer type 1 susceptibility protein isoform 110

    Status: REVIEWED

    Source sequence(s)
    AC135721

  288. NM_001408433.1 → NP_001395362.1  breast cancer type 1 susceptibility protein isoform 110

    Status: REVIEWED

    Source sequence(s)
    AC135721

  289. NM_001408434.1 → NP_001395363.1  breast cancer type 1 susceptibility protein isoform 110

    Status: REVIEWED

    Source sequence(s)
    AC135721

  290. NM_001408435.1 → NP_001395364.1  breast cancer type 1 susceptibility protein isoform 110

    Status: REVIEWED

    Source sequence(s)
    AC135721

  291. NM_001408436.1 → NP_001395365.1  breast cancer type 1 susceptibility protein isoform 111

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQF1

  292. NM_001408437.1 → NP_001395366.1  breast cancer type 1 susceptibility protein isoform 111

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQF1

  293. NM_001408438.1 → NP_001395367.1  breast cancer type 1 susceptibility protein isoform 111

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQF1

  294. NM_001408439.1 → NP_001395368.1  breast cancer type 1 susceptibility protein isoform 111

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQF1
    Related
    ENSP00000419481.2, ENST00000484087.6

  295. NM_001408440.1 → NP_001395369.1  breast cancer type 1 susceptibility protein isoform 111

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQF1

  296. NM_001408441.1 → NP_001395370.1  breast cancer type 1 susceptibility protein isoform 112

    Status: REVIEWED

    Source sequence(s)
    AC135721

  297. NM_001408442.1 → NP_001395371.1  breast cancer type 1 susceptibility protein isoform 112

    Status: REVIEWED

    Source sequence(s)
    AC135721

  298. NM_001408443.1 → NP_001395372.1  breast cancer type 1 susceptibility protein isoform 112

    Status: REVIEWED

    Source sequence(s)
    AC135721

  299. NM_001408444.1 → NP_001395373.1  breast cancer type 1 susceptibility protein isoform 112

    Status: REVIEWED

    Source sequence(s)
    AC135721

  300. NM_001408445.1 → NP_001395374.1  breast cancer type 1 susceptibility protein isoform 113

    Status: REVIEWED

    Source sequence(s)
    AC135721

  301. NM_001408446.1 → NP_001395375.1  breast cancer type 1 susceptibility protein isoform 113

    Status: REVIEWED

    Source sequence(s)
    AC135721

  302. NM_001408447.1 → NP_001395376.1  breast cancer type 1 susceptibility protein isoform 113

    Status: REVIEWED

    Source sequence(s)
    AC135721

  303. NM_001408448.1 → NP_001395377.1  breast cancer type 1 susceptibility protein isoform 113

    Status: REVIEWED

    Source sequence(s)
    AC135721

  304. NM_001408450.1 → NP_001395379.1  breast cancer type 1 susceptibility protein isoform 113

    Status: REVIEWED

    Source sequence(s)
    AC135721

  305. NM_001408451.1 → NP_001395380.1  breast cancer type 1 susceptibility protein isoform 114

    Status: REVIEWED

    Source sequence(s)
    AC135721

  306. NM_001408452.1 → NP_001395381.1  breast cancer type 1 susceptibility protein isoform 115

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A2R8Y587, A0A9Y1QPT7

  307. NM_001408453.1 → NP_001395382.1  breast cancer type 1 susceptibility protein isoform 115

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A2R8Y587, A0A9Y1QPT7

  308. NM_001408454.1 → NP_001395383.1  breast cancer type 1 susceptibility protein isoform 115

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A2R8Y587, A0A9Y1QPT7
    Related
    ENSP00000418819.2, ENST00000493919.6

  309. NM_001408455.1 → NP_001395384.1  breast cancer type 1 susceptibility protein isoform 115

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A2R8Y587, A0A9Y1QPT7

  310. NM_001408456.1 → NP_001395385.1  breast cancer type 1 susceptibility protein isoform 115

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A2R8Y587, A0A9Y1QPT7

  311. NM_001408457.1 → NP_001395386.1  breast cancer type 1 susceptibility protein isoform 115

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A2R8Y587, A0A9Y1QPT7

  312. NM_001408458.1 → NP_001395387.1  breast cancer type 1 susceptibility protein isoform 116

    Status: REVIEWED

    Source sequence(s)
    AC060780, AC135721
    UniProtKB/TrEMBL
    B4DES0

  313. NM_001408459.1 → NP_001395388.1  breast cancer type 1 susceptibility protein isoform 116

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    B4DES0

  314. NM_001408460.1 → NP_001395389.1  breast cancer type 1 susceptibility protein isoform 116

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    B4DES0

  315. NM_001408461.1 → NP_001395390.1  breast cancer type 1 susceptibility protein isoform 116

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    B4DES0

  316. NM_001408462.1 → NP_001395391.1  breast cancer type 1 susceptibility protein isoform 117

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQ47

  317. NM_001408463.1 → NP_001395392.1  breast cancer type 1 susceptibility protein isoform 117

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQ47

  318. NM_001408464.1 → NP_001395393.1  breast cancer type 1 susceptibility protein isoform 117

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQ47

  319. NM_001408465.1 → NP_001395394.1  breast cancer type 1 susceptibility protein isoform 117

    Status: REVIEWED

    Source sequence(s)
    AC135721
    UniProtKB/TrEMBL
    A0A9Y1QQ47

  320. NM_001408466.1 → NP_001395395.1  breast cancer type 1 susceptibility protein isoform 118

    Status: REVIEWED

    Source sequence(s)
    AC135721

  321. NM_001408467.1 → NP_001395396.1  breast cancer type 1 susceptibility protein isoform 118

    Status: REVIEWED

    Source sequence(s)
    AC135721

  322. NM_001408468.1 → NP_001395397.1  breast cancer type 1 susceptibility protein isoform 119

    Status: REVIEWED

    Source sequence(s)
    AC135721

  323. NM_001408469.1 → NP_001395398.1  breast cancer type 1 susceptibility protein isoform 120

    Status: REVIEWED

    Source sequence(s)
    AC135721

  324. NM_001408470.1 → NP_001395399.1  breast cancer type 1 susceptibility protein isoform 121

    Status: REVIEWED

    Source sequence(s)
    AC135721

  325. NM_001408472.1 → NP_001395401.1  breast cancer type 1 susceptibility protein isoform 122

    Status: REVIEWED

    Source sequence(s)
    AC135721

  326. NM_001408473.1 → NP_001395402.1  breast cancer type 1 susceptibility protein isoform 123

    Status: REVIEWED

    Source sequence(s)
    AC135721

  327. NM_001408474.1 → NP_001395403.1  breast cancer type 1 susceptibility protein isoform 124

    Status: REVIEWED

    Source sequence(s)
    AC135721

  328. NM_001408475.1 → NP_001395404.1  breast cancer type 1 susceptibility protein isoform 125

    Status: REVIEWED

    Source sequence(s)
    AC135721

  329. NM_001408476.1 → NP_001395405.1  breast cancer type 1 susceptibility protein isoform 126

    Status: REVIEWED

    Source sequence(s)
    AC135721

  330. NM_001408478.1 → NP_001395407.1  breast cancer type 1 susceptibility protein isoform 127

    Status: REVIEWED

    Source sequence(s)
    AC135721

  331. NM_001408479.1 → NP_001395408.1  breast cancer type 1 susceptibility protein isoform 127

    Status: REVIEWED

    Source sequence(s)
    AC135721

  332. NM_001408480.1 → NP_001395409.1  breast cancer type 1 susceptibility protein isoform 127

    Status: REVIEWED

    Source sequence(s)
    AC135721

  333. NM_001408481.1 → NP_001395410.1  breast cancer type 1 susceptibility protein isoform 128

    Status: REVIEWED

    Source sequence(s)
    AC135721

  334. NM_001408482.1 → NP_001395411.1  breast cancer type 1 susceptibility protein isoform 128

    Status: REVIEWED

    Source sequence(s)
    AC135721

  335. NM_001408483.1 → NP_001395412.1  breast cancer type 1 susceptibility protein isoform 128

    Status: REVIEWED

    Source sequence(s)
    AC135721

  336. NM_001408484.1 → NP_001395413.1  breast cancer type 1 susceptibility protein isoform 128

    Status: REVIEWED

    Source sequence(s)
    AC135721

  337. NM_001408485.1 → NP_001395414.1  breast cancer type 1 susceptibility protein isoform 128

    Status: REVIEWED

    Source sequence(s)
    AC135721

  338. NM_001408489.1 → NP_001395418.1  breast cancer type 1 susceptibility protein isoform 129

    Status: REVIEWED

    Source sequence(s)
    AC135721

  339. NM_001408490.1 → NP_001395419.1  breast cancer type 1 susceptibility protein isoform 130

    Status: REVIEWED

    Source sequence(s)
    AC135721

  340. NM_001408491.1 → NP_001395420.1  breast cancer type 1 susceptibility protein isoform 130

    Status: REVIEWED

    Source sequence(s)
    AC135721

  341. NM_001408492.1 → NP_001395421.1  breast cancer type 1 susceptibility protein isoform 131

    Status: REVIEWED

    Source sequence(s)
    AC135721

  342. NM_001408493.1 → NP_001395422.1  breast cancer type 1 susceptibility protein isoform 132

    Status: REVIEWED

    Source sequence(s)
    AC135721

  343. NM_001408494.1 → NP_001395423.1  breast cancer type 1 susceptibility protein isoform 133

    Status: REVIEWED

    Source sequence(s)
    AC135721

  344. NM_001408495.1 → NP_001395424.1  breast cancer type 1 susceptibility protein isoform 134

    Status: REVIEWED

    Source sequence(s)
    AC135721

  345. NM_001408496.1 → NP_001395425.1  breast cancer type 1 susceptibility protein isoform 135

    Status: REVIEWED

    Source sequence(s)
    AC135721

  346. NM_001408497.1 → NP_001395426.1  breast cancer type 1 susceptibility protein isoform 135

    Status: REVIEWED

    Source sequence(s)
    AC135721

  347. NM_001408498.1 → NP_001395427.1  breast cancer type 1 susceptibility protein isoform 135

    Status: REVIEWED

    Source sequence(s)
    AC135721

  348. NM_001408499.1 → NP_001395428.1  breast cancer type 1 susceptibility protein isoform 135

    Status: REVIEWED

    Source sequence(s)
    AC135721

  349. NM_001408500.1 → NP_001395429.1  breast cancer type 1 susceptibility protein isoform 135

    Status: REVIEWED

    Source sequence(s)
    AC135721

  350. NM_001408501.1 → NP_001395430.1  breast cancer type 1 susceptibility protein isoform 135

    Status: REVIEWED

    Source sequence(s)
    AC135721

  351. NM_001408502.1 → NP_001395431.1  breast cancer type 1 susceptibility protein isoform 136

    Status: REVIEWED

    Source sequence(s)
    AC135721

  352. NM_001408503.1 → NP_001395432.1  breast cancer type 1 susceptibility protein isoform 137

    Status: REVIEWED

    Source sequence(s)
    AC135721

  353. NM_001408504.1 → NP_001395433.1  breast cancer type 1 susceptibility protein isoform 137

    Status: REVIEWED

    Source sequence(s)
    AC135721

  354. NM_001408505.1 → NP_001395434.1  breast cancer type 1 susceptibility protein isoform 138

    Status: REVIEWED

    Source sequence(s)
    AC135721

  355. NM_001408506.1 → NP_001395435.1  breast cancer type 1 susceptibility protein isoform 139

    Status: REVIEWED

    Source sequence(s)
    AC135721

  356. NM_001408507.1 → NP_001395436.1  breast cancer type 1 susceptibility protein isoform 140

    Status: REVIEWED

    Source sequence(s)
    AC135721

  357. NM_001408508.1 → NP_001395437.1  breast cancer type 1 susceptibility protein isoform 141

    Status: REVIEWED

    Source sequence(s)
    AC135721

  358. NM_001408509.1 → NP_001395438.1  breast cancer type 1 susceptibility protein isoform 142

    Status: REVIEWED

    Source sequence(s)
    AC135721

  359. NM_001408510.1 → NP_001395439.1  breast cancer type 1 susceptibility protein isoform 143

    Status: REVIEWED

    Source sequence(s)
    AC135721

  360. NM_001408511.1 → NP_001395440.1  breast cancer type 1 susceptibility protein isoform 144

    Status: REVIEWED

    Source sequence(s)
    AC135721

  361. NM_001408512.1 → NP_001395441.1  breast cancer type 1 susceptibility protein isoform 145

    Status: REVIEWED

    Source sequence(s)
    AC135721

  362. NM_001408513.1 → NP_001395442.1  breast cancer type 1 susceptibility protein isoform 146

    Status: REVIEWED

    Source sequence(s)
    AC135721

  363. NM_001408514.1 → NP_001395443.1  breast cancer type 1 susceptibility protein isoform 147

    Status: REVIEWED

    Source sequence(s)
    AC135721

  364. NM_007294.4 → NP_009225.1  breast cancer type 1 susceptibility protein isoform 1

    See identical proteins and their annotated locations for NP_009225.1

    Status: REVIEWED

    Source sequence(s)
    AL701927, BC072418, BU617173, BU679389, U14680
    Consensus CDS
    CCDS11453.1
    UniProtKB/Swiss-Prot
    E9PFZ0, O15129, P38398, Q1RMC1, Q3LRJ0, Q3LRJ6, Q6IN79, Q7KYU9
    UniProtKB/TrEMBL
    A0A386INP3, A0A386IPK6, G8I0D8
    Related
    ENSP00000350283.3, ENST00000357654.9
    Conserved Domains (4) summary
    smart00292
    Location:1758 → 1842
    BRCT; breast cancer carboxy-terminal domain
    cd00027
    Location:1650 → 1724
    BRCT; Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain. The BRCT domain is found within many DNA damage repair and cell cycle checkpoint proteins. The unique diversity of this domain superfamily allows BRCT modules to interact forming homo ...
    cd00162
    Location:23 → 68
    RING; RING-finger (Really Interesting New Gene) domain, a specialized type of Zn-finger of 40 to 60 residues that binds two atoms of zinc; defined by the 'cross-brace' motif C-X2-C-X(9-39)-C-X(1-3)- H-X(2-3)-(N/C/H)-X2-C-X(4-48)C-X2-C; probably involved in ...
    pfam12820
    Location:345 → 507
    BRCT_assoc; Serine-rich domain associated with BRCT

  365. NM_007297.4 → NP_009228.2  breast cancer type 1 susceptibility protein isoform 3

    Status: REVIEWED

    Source sequence(s)
    BC072418, BU617173, BU679389, U14680
    Consensus CDS
    CCDS11459.2
    UniProtKB/TrEMBL
    A0A386INP3, A0A9Y1QQK3
    Related
    ENSP00000418775.1, ENST00000493795.5
    Conserved Domains (3) summary
    smart00292
    Location:1711 → 1795
    BRCT; breast cancer carboxy-terminal domain
    cd00027
    Location:1603 → 1677
    BRCT; Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain. The BRCT domain is found within many DNA damage repair and cell cycle checkpoint proteins. The unique diversity of this domain superfamily allows BRCT modules to interact forming homo ...
    pfam12820
    Location:298 → 460
    BRCT_assoc; Serine-rich domain associated with BRCT

  366. NM_007298.4 → NP_009229.2  breast cancer type 1 susceptibility protein isoform 4

    See identical proteins and their annotated locations for NP_009229.2

    Status: REVIEWED

    Source sequence(s)
    AC135721
    Consensus CDS
    CCDS11454.2
    UniProtKB/TrEMBL
    A0A9Y1QQL7
    Conserved Domains (3) summary
    smart00292
    Location:654 → 738
    BRCT; breast cancer carboxy-terminal domain
    cd00027
    Location:546 → 620
    BRCT; Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain. The BRCT domain is found within many DNA damage repair and cell cycle checkpoint proteins. The unique diversity of this domain superfamily allows BRCT modules to interact forming homo ...
    cd00162
    Location:23 → 68
    RING; RING-finger (Really Interesting New Gene) domain, a specialized type of Zn-finger of 40 to 60 residues that binds two atoms of zinc; defined by the 'cross-brace' motif C-X2-C-X(9-39)-C-X(1-3)- H-X(2-3)-(N/C/H)-X2-C-X(4-48)C-X2-C; probably involved in ...

  367. NM_007299.4 → NP_009230.2  breast cancer type 1 susceptibility protein isoform 5

    See identical proteins and their annotated locations for NP_009230.2

    Status: REVIEWED

    Source sequence(s)
    BC072418, BU617173, BU679389
    Consensus CDS
    CCDS11455.2
    UniProtKB/TrEMBL
    A0A9Y1QPQ7
    Related
    ENSP00000417148.1, ENST00000468300.5
    Conserved Domains (2) summary
    pfam00533
    Location:546 → 619
    BRCT; BRCA1 C Terminus (BRCT) domain
    cd16498
    Location:18 → 65
    RING-HC_BRCA1; RING finger, HC subclass, found in breast cancer type 1 susceptibility protein (BRCA1) and similar proteins

  368. NM_007300.4 → NP_009231.2  breast cancer type 1 susceptibility protein isoform 2

    Status: REVIEWED

    Source sequence(s)
    AC135721, BC072418, BC115037, BU617173, BU679389, U14680
    Consensus CDS
    CCDS11456.2
    UniProtKB/TrEMBL
    A0A386INP3, A0A386IPK6, G8I0D8
    Related
    ENSP00000418960.2, ENST00000471181.7
    Conserved Domains (4) summary
    smart00292
    Location:1779 → 1863
    BRCT; breast cancer carboxy-terminal domain
    cd00027
    Location:1671 → 1745
    BRCT; Breast Cancer Suppressor Protein (BRCA1), carboxy-terminal domain. The BRCT domain is found within many DNA damage repair and cell cycle checkpoint proteins. The unique diversity of this domain superfamily allows BRCT modules to interact forming homo ...
    cd00162
    Location:23 → 68
    RING; RING-finger (Really Interesting New Gene) domain, a specialized type of Zn-finger of 40 to 60 residues that binds two atoms of zinc; defined by the 'cross-brace' motif C-X2-C-X(9-39)-C-X(1-3)- H-X(2-3)-(N/C/H)-X2-C-X(4-48)C-X2-C; probably involved in ...
    pfam12820
    Location:345 → 507
    BRCT_assoc; Serine-rich domain associated with BRCT

RefSeqs of Annotated Genomes: GCF_000001405.40-RS_2024_08

The following sections contain reference sequences that belong to a specific genome build. Explain

Reference GRCh38.p14 Primary Assembly

Genomic

  1. NC_000017.11 Reference GRCh38.p14 Primary Assembly

    Range
    43044295..43170327 complement
    Download
    GenBank, FASTA, Sequence Viewer (Graphics)

Alternate T2T-CHM13v2.0

Genomic

  1. NC_060941.1 Alternate T2T-CHM13v2.0

    Range
    43902857..44029084 complement
    Download
    GenBank, FASTA, Sequence Viewer (Graphics)

Suppressed Reference Sequence(s)

The following Reference Sequences have been suppressed. Explain

  1. NM_007295.2: Suppressed sequence

    Description
    NM_007295.2: This RefSeq was permanently suppressed because only partial transcript evidence exists for this transcript variant, and its full-length exon combination is unclear.

  2. NM_007296.2: Suppressed sequence

    Description
    NM_007296.2: This RefSeq was permanently suppressed because there is no full-length transcript support for the exon combination of this variant.

  3. NM_007301.2: Suppressed sequence

    Description
    NM_007301.2: This RefSeq was permanently suppressed because currently there is insufficient support for the transcript and the protein.

  4. NM_007302.2: Suppressed sequence

    Description
    NM_007302.2: This RefSeq was permanently suppressed because only partial transcript evidence exists for this transcript variant, and its full-length exon combination is unclear.

  5. NM_007303.2: Suppressed sequence

    Description
    NM_007303.2: This RefSeq was permanently suppressed because the full-length sequence of this transcript variant is unavailable, and its full-length exon combination is unclear.

  6. NM_007305.2: Suppressed sequence

    Description
    NM_007305.2: This RefSeq was permanently suppressed because the full-length sequence of this transcript variant is unavailable, and its full-length exon combination is unclear.

  7. NM_007306.2: Suppressed sequence

    Description
    NM_007306.2: This RefSeq was permanently suppressed because currently there is insufficient support for the transcript and the protein.
Nucleotide Protein
Heading Accession and Version
Protein Accession Links
GenPept Link UniProtKB Link
P38398.2 GenPept UniProtKB/Swiss-Prot:P38398

Gene LinkOut

The following LinkOut resources are supplied by external providers. These providers are responsible for maintaining the links.

Chemical Information
Medical
Molecular Biology Databases
Research Materials
Tools
Miscellaneous